NCT06405490
- Conditions
- Advanced Cancer, Cadonilimab, Capecitabine, +5 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Clinical trial condition
First-Line
Explore clinical trials studying First-Line. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
First-Line trial results
NCT05970302
- Conditions
- Bevacizumab, Capecitabine, Colonic Diseases, +16 more
- Locations
-
- Lin Yang Beijing, China
Not Yet Recruiting
Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
NCT06621095
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- Renji hospital Shanghai, Shanghai Municipality, China